Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/14221
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBROUX, Bieke-
dc.contributor.authorMarkovic-Plese, Silva-
dc.contributor.authorSTINISSEN, Piet-
dc.contributor.authorHELLINGS, Niels-
dc.date.accessioned2012-09-28T11:31:29Z-
dc.date.available2012-09-28T11:31:29Z-
dc.date.issued2012-
dc.identifier.citationTRENDS IN MOLECULAR MEDICINE, 18 (8), p. 446-453-
dc.identifier.issn1471-4914-
dc.identifier.urihttp://hdl.handle.net/1942/14221-
dc.description.abstractAging of the immune system contributes to the increased morbidity and mortality of the elderly population and may occur prematurely in patients with immune disorders. One of the main characteristics of immunosenescence is the expansion of CD4(+)CD28(-) T cells in the blood. These cells are effector memory T cells with cytotoxic capacity, and have been recently described to have pathogenic potential in a variety of immune disorders. Interestingly, CD4(+)CD28(-) T cells have now been found to infiltrate target tissues of patients with multiple sclerosis, rheumatoid arthritis, myopathies, acute coronary syndromes, and other immune-related diseases. In this review, we discuss potential factors and mechanisms that may induce the expansion of these cells, as well as their putative pathogenic mechanisms in immune disorders.-
dc.description.sponsorshipThis work was supported by Hasselt University, Belgian Charcot Foundation, and FWO Flanders. The authors have no conflicting financial interests.-
dc.language.isoen-
dc.publisherELSEVIER SCI LTD-
dc.subject.otherBiochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental-
dc.titlePathogenic features of CD4(+)CD28(-) T cells in immune disorders-
dc.typeJournal Contribution-
dc.identifier.epage453-
dc.identifier.issue8-
dc.identifier.spage446-
dc.identifier.volume18-
local.format.pages8-
local.bibliographicCitation.jcatA1-
dc.description.notes[Broux, Bieke; Stinissen, Piet; Hellings, Niels] Hasselt Univ, Biomed Res Inst, B-3590 Diepenbeek, Belgium. [Broux, Bieke; Stinissen, Piet; Hellings, Niels] Transnat Univ Limburg, Sch Life Sci, B-3590 Diepenbeek, Belgium. [Markovic-Plese, Silva] Univ N Carolina, Dept Neurol, Chapel Hill, NC 27514 USA. [Markovic-Plese, Silva] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27514 USA. niels.hellings@uhasselt.be-
local.publisher.placeOXFORD-
local.type.refereedRefereed-
local.type.specifiedReview-
dc.bibliographicCitation.oldjcatA1-
dc.identifier.doi10.1016/j.molmed.2012.06.003-
dc.identifier.isi000307912300003-
item.accessRightsRestricted Access-
item.validationecoom 2013-
item.fulltextWith Fulltext-
item.contributorBROUX, Bieke-
item.contributorMarkovic-Plese, Silva-
item.contributorSTINISSEN, Piet-
item.contributorHELLINGS, Niels-
item.fullcitationBROUX, Bieke; Markovic-Plese, Silva; STINISSEN, Piet & HELLINGS, Niels (2012) Pathogenic features of CD4(+)CD28(-) T cells in immune disorders. In: TRENDS IN MOLECULAR MEDICINE, 18 (8), p. 446-453.-
crisitem.journal.issn1471-4914-
crisitem.journal.eissn1471-499X-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
broux 1.pdf
  Restricted Access
Published version627.82 kBAdobe PDFView/Open    Request a copy
Show simple item record

SCOPUSTM   
Citations

75
checked on Sep 2, 2020

WEB OF SCIENCETM
Citations

90
checked on Apr 30, 2024

Page view(s)

60
checked on Aug 30, 2022

Download(s)

46
checked on Aug 30, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.